1. Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
   Zhen Yang et al, 2020, Front. Physiol. CrossRef
2. Qingxin Kaiqiao Fang Inhibits Aβ25-35-Induced Apoptosis in Primary Cultured Rat Hippocampal Neuronal Cells via the p38 MAPK Pathway: An Experimental Validation and Network Pharmacology Study
   Tian-Qi Wang et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
3. p38 MAPK Pathway in the Heart: New Insights in Health and Disease.
   Rafael Romero-Becerra et al, 2020, Int J Mol Sci CrossRef
4. Expression of cell adhesion molecule, Gicerin/CD146 during the formation of heart and in the cardiac hypertrophy
   Mami Obara et al, 2021, Mol Cell Biochem CrossRef
5. Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
   Podsawee Mongkolpathumrat et al, 2021, Biomedicines CrossRef
6. Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: role of AMPK/SIRT1 activation and DPP-4 inhibition
   Nehal S. Wahba et al, 2020, Can. J. Physiol. Pharmacol. CrossRef
7. Rutaecarpine attenuates high glucose‐induced damage in AC16 cardiomyocytes by suppressing the MAPK pathway
   Jun Lv et al, 2023, J of Applied Toxicology CrossRef
8. Role of mechanotransduction mediated by YAP/TAZ in the treatment of neurogenic erectile dysfunction with low‐intensity pulsed ultrasound
   Yang Liu et al, 2023, Andrology CrossRef
9. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing
   Stéphanie Barrère-Lemaire et al, 2024, Physiological Reviews CrossRef